AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Investigational new drug applications filed for M-Vax, O-Vax.(Brief Article)

Vaccine Weekly

| November 06, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced the submission of investigational new drug applications (IND) for M-Vax and O-Vax, its AC Vaccine technology product candidates for the treatment of melanoma and ovarian cancers, with the U.S. Food and Drug Administration (FDA).

If, after a 30-day review period FDA has no questions, the company will be able to commence its clinical trials.

David L. Tousley, president and chief operating officer of Avax stated, "This is an important milestone in the continuing development of the frozen AC Vaccine technology. Our team has done a great job in completing the necessary product development activities, assay development and facility and quality system modifications leading to the submission of these INDs and ensuring that we are ready to carry out the clinical trials."

The endpoints for these ...

Related articles from newspapers, magazines, journals, and more
AVAX Technologies' M-Vax(TM) Cancer Vaccine Extends Five-Year Overall Survival...
Press release article from: PR Newswire May 23, 2000 700+ words
...autologous cell vaccine (AC Vaccine(TM)) M-Vax(TM) for the treatment...the ability of M-Vax to produce a positive...activity of the AC Vaccine(TM) technology...mid-2000. The AC Vaccine technology is also...ovarian cancer (O-Vax(TM)), a Phase...
AVAX Technologies Announces Special Protocol Assessment Agreement with FDA for...
Press release article from: Business Wire October 12, 2006 700+ words
...clinical trial for M-Vax, the Company's AC Vaccine technology for the...marketing approval of M-VAX," said Richard P...potency assay for the AC Vaccine Technology." Initiation...Commission. About M-Vax (the AC Vaccine Product Candidate...
AVAX Melanoma Vaccine M-Vax(TM) Nearing Commercialization In the Netherlands,...
Press release article from: PR Newswire September 14, 1999 700+ words
...our investors." M-Vax is the first of several...AVAX's proprietary AC Vaccine(TM) technology...been treated with M-Vax on an outpatient basis...United States. O-Vax(TM), the company's AC Vaccine for Stage 3 and advanced...
AVAX Technologies Launches Global Phase III Registration Clinical Trial of...
Press release article from: Business Wire November 29, 2006 700+ words
...III Registration Study for M-Vax, its AC Vaccine Therapeutic for the treatment...for accelerated approval of M-Vax and the statistical analysis...Exchange Commission. About M-Vax (the AC Vaccine Product Candidate for the Treatment...
AVAX Technologies Awarded Orphan Drug Status for Its O-Vax(TM) Ovarian Cancer...
Press release article from: PR Newswire September 27, 2000 700+ words
...Vaccine technology (AC Vaccine(TM)) for the treatment...adjuvant therapy, O-Vax(TM), received...applications for our AC Vaccine technology. O-Vax joins M-Vax(TM...ovarian cancer (O-Vax). The AC Vaccine technology is also...
AVAX Technologies' O-Vax(TM) Cancer Vaccine Induces Positive Immunological and...
Press release article from: PR Newswire May 22, 2000 700+ words
...autologous cell vaccine (AC Vaccine(TM)) O-Vax(TM), for ovarian...multi-center O-Vax studies that are...expect to use the AC Vaccine to treat other cancer...treating cancer." O-Vax is AVAX Technolgies' AC Vaccine for the treatment...
Melanoma Vaccine M-Vax(TM) Shows Promise in the Most Advanced Cases of Stage...
Press release article from: PR Newswire April 13, 1999 700+ words
...cell vaccine (AC Vaccine(TM)), M-Vax(TM), appears...utility of AVAX's AC Vaccine(TM) technology...registration trial for M-Vax in patients with...effectiveness of the AC Vaccine(TM) not only...ovarian cancer (O-Vax(TM)), but...
AVAX Technologies Extends Findings of Experimental Cancer Vaccine O-Vax(TM).
Press release article from: PR Newswire May 13, 1999 700+ words
...Phase 1 trials of O-Vax(TM), one of the...autologous cell vaccines (AC Vaccine(TM)) for the treatment...surgical treatment with O-Vax appears to induce immune...Cancer Institute." O-Vax is AVAX Technolgies' AC Vaccine for the treatment of...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA